EUVIMEDEUVIMED entdecken
Crossref

Continuous renal replacement therapy and therapeutic plasma exchange in pediatric liver failure

Caroline Jackson, Kristen Carlin, Niviann Blondet, Ian Jordan, Larissa Yalon, Patrick J Healey, Jordan M Symons, Shina Menon

European Journal of Pediatrics · 2024

DOI: 10.1007/s00431-024-05587-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Caroline Jackson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Plasma Exchange, Continuous Renal Replacement Therapy, Liver Failure, Acute, Acute-On-Chronic Liver Failure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Dorothy and Gordon Sparks Nephrology Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with acute liver failure (ALF) and acute on chronic liver failure (ACLF) have significant morbidity and mortality. They require extracorporeal blood purification modalities like continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) as a bridge to recovery or liver transplantation. Limited data are available on the outcomes of patients treated with these therapies. This is a retrospective single-center study of 23 patients from 2015 to 2022 with ALF/ACLF who underwent CRRT and TPE. We aimed to describe the clinical characteristics and outcomes of these patients. Median (IQR) age was 0.93 years (0.57, 9.88), range 16 days to 20 years. Ten (43%) had ALF and 13 (57%) ACLF. Most (n = 19, 82%) started CRRT for hyperammonemia and/or hepatic encephalopathy and all received TPE for refractory coagulopathy. CRRT was started at a median of 2 days from ICU admission, and TPE started on the same day in most. The liver transplant was done in 17 (74%), and 2 recovered native liver function. Four patients, all with ACLF, died prior to ICU discharge without a liver transplant. The median peak ammonia pre-CRRT was 131 µmol/L for the whole cohort. The mean (SD) drop in ammonia after 48 h of CRRT was 95.45 (43.72) µmol/L in those who survived and 69.50 (21.70) µmol/L in those who did not (p 0.26). Those who survived had 0 median co-morbidities compared to 2.5 in non-survivors (aOR (95% CI) for mortality risk of 2.5 (1.1-5.7), p 0.028). Conclusion: In this cohort of 23 pediatric patients with ALF or ACLF who received CRRT and TPE, 83% survived with a liver transplant or recovered with their native liver. Survival was worse in those who had ACLF and those with co-morbid conditions. What is Known: • Pediatric acute liver failure is associated with high mortality. • Patients may require extracorporeal liver assist therapies (like CRRT, TPE, MARS, SPAD) to bridge them over to a transplant or recovery of native liver function. What is New: • Standard volume plasma exhange has not been evaluated against high volume plasma exchange for ALF. • The role, dose, and duration of therapeutic plasma exchange in patients with acute on chronic liver failure is not well described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangeContinuous Renal Replacement TherapyLiver Failure, AcuteAcute-On-Chronic Liver FailureHumansRetrospective StudiesMaleFemaleChildChild, PreschoolInfantAdolescentYoung AdultInfant, NewbornTreatment OutcomeLiver Transplantation

Stichwörter der Autor:innen

Acute kidney injuryAcute liver failureContinuous kidney replacement therapyLiver transplantTherapeutic plasma exchange

Autor:innen und Institutionen

  • Division of Nephrology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
  • Seattle Children's Research Institute, Seattle, WA, USA.
  • Division of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
  • Seattle Children's Hospital, Seattle, WA, USA.
  • Department of Surgery, Seattle Children's Hospital, Seattle, WA, USA.
  • Division of Nephrology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. shinam@stanford.edu.

Förderung

  • Dorothy and Gordon Sparks Nephrology Research Fund

Zitieren

APA

Jackson, C., Carlin, K., Blondet, N., Jordan, I., Yalon, L., Healey, P. J., Symons, J. M., & Menon, S. (2024). Continuous renal replacement therapy and therapeutic plasma exchange in pediatric liver failure. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05587-3

Vancouver

Jackson C, Carlin K, Blondet N, Jordan I, Yalon L, Healey PJ, et al. Continuous renal replacement therapy and therapeutic plasma exchange in pediatric liver failure. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05587-3

BibTeX
@article{Jackson2024,
  author = {Jackson, Caroline and Carlin, Kristen and Blondet, Niviann and Jordan, Ian and Yalon, Larissa and Healey, Patrick J and Symons, Jordan M and Menon, Shina},
  title = {Continuous renal replacement therapy and therapeutic plasma exchange in pediatric liver failure},
  journal = {European Journal of Pediatrics},
  year = {2024},
  doi = {10.1007/s00431-024-05587-3}
}
Kostenlos starten →